Effects of Hemosiderosis on Epilepsy Following Subarachnoid Hemorrhage.
epilepsy
hemosiderosis
seizure
subarachnoid hemorrhage
Journal
Neurologia medico-chirurgica
ISSN: 1349-8029
Titre abrégé: Neurol Med Chir (Tokyo)
Pays: Japan
ID NLM: 0400775
Informations de publication
Date de publication:
15 Jan 2019
15 Jan 2019
Historique:
pubmed:
21
12
2018
medline:
7
5
2019
entrez:
21
12
2018
Statut:
ppublish
Résumé
Epilepsy after aneurysmal subarachnoid hemorrhage (post-SAH epilepsy) is a critical complication that influences clinical and social prognoses. However, the underlying mechanisms remain unclear. We investigated the relationship between hemosiderosis and the incidence of post-SAH epilepsy. About 50 patients with aneurysmal SAH who were admitted to Sapporo Medical University and Oji General Hospital between April 2010 and June 2016 were enrolled in this retrospective study. Hemosiderosis detected by T2*-weighted magnetic resonance imaging(MRI) and the incidence of post-SAH epilepsy were retrospectively analyzed. Post-SAH epilepsy was defined as an unprovoked seizures occurring more than 1 week after the onset of SAH. Six patients (12%) developed post-SAH epilepsy. In all patients, hemosiderosis in the cortex or cerebral parenchyma was detected by T2*-weighted MRI. Statistical analyses revealed that hemosiderosis and the co-existence of intracerebral hemorrhage (ICH) related with post-SAH epilepsy (Fisher's exact test, univariate exact logistic regression analysis: P < 0.05). Post-SAH epilepsy was predicted by hemosiderosis and the co-existence of ICH. The present results suggest that hemosiderin is the principal cause of post-SAH epilepsy and may be a predictor of this critical complication.
Identifiants
pubmed: 30568071
doi: 10.2176/nmc.oa.2018-0125
pmc: PMC6350000
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
27-32Références
Neurology. 1999 Jul 13;53(1):162-6
pubmed: 10408553
Neurology. 2003 Jan 28;60(2):208-14
pubmed: 12552032
Neurosurgery. 2003 Mar;52(3):545-52; discussion 550-2
pubmed: 12590678
Stroke. 2003 Jul;34(7):1693-8
pubmed: 12805503
Acta Neurochir (Wien). 1992;119(1-4):49-52
pubmed: 1481752
Lancet. 2005 Sep 3-9;366(9488):809-17
pubmed: 16139655
Epilepsia. 2006 Mar;47(3):563-6
pubmed: 16529622
Lancet. 2007 Jan 27;369(9558):306-18
pubmed: 17258671
Eur J Neurol. 2008 May;15(5):451-7
pubmed: 18325027
Acta Neurochir (Wien). 1990;106(3-4):115-8
pubmed: 2126663
Epilepsia. 2014 Apr;55(4):475-82
pubmed: 24730690
Neurocrit Care. 2015 Jun;22(3):450-61
pubmed: 25277888
Neurology. 2015 Jun 2;84(22):2229-37
pubmed: 25948726
Epilepsia. 2017 Apr;58(4):522-530
pubmed: 28276060
Neurosurgery. 1985 Dec;17(6):897-900
pubmed: 4080121
Epilepsia. 1994;35 Suppl 6:S30-43
pubmed: 8206013
Neurosurgery. 1993 Aug;33(2):179-88; discussion 188
pubmed: 8367039
Neurology. 1993 Apr;43(4):712-8
pubmed: 8469328
Stroke. 1998 Apr;29(4):798-804
pubmed: 9550514